Source:http://linkedlifedata.com/resource/pubmed/id/16380594
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2005-12-28
|
pubmed:abstractText |
X-linked adrenoleukodystrophy (X-ALD), which was first described in 1923, was viewed until 1976 as a rare and inexorably fatal neurodegenerative disorder that affected boys. The genetic defect and biochemical abnormalities have now been defined. Ongoing research has resulted in new findings: (1) there is a wide range of phenotypic expression. At least half of patients with X-ALD are adults with somewhat milder manifestations, and women who are carriers may become symptomatic. X-ALD is often misdiagnosed as attention-deficit/hyperactivity disorder in boys and as multiple sclerosis in men and women, and is not an uncommon cause of Addison disease; (2) the incidence of X-ALD, estimated to be 1:17,000 in all ethnic groups, approximates that of phenylketonuria; (3) noninvasive and presymptomatic diagnosis and prenatal diagnosis are available; family screening and genetic counseling are key to disease prevention; and (4) new therapies, applied early, show promise. Neonatal screening is likely to become available, and a wider awareness of X-ALD and its various modes of presentation permit new proactive approaches to this distressing disorder.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenal Cortex Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Erucic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Fatty Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Lorenzo's oil,
http://linkedlifedata.com/resource/pubmed/chemical/Triolein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1538-3598
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
294
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3131-4
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16380594-Adrenal Cortex Hormones,
pubmed-meshheading:16380594-Adrenoleukodystrophy,
pubmed-meshheading:16380594-Drug Combinations,
pubmed-meshheading:16380594-Erucic Acids,
pubmed-meshheading:16380594-Fatty Acids,
pubmed-meshheading:16380594-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:16380594-Hormone Replacement Therapy,
pubmed-meshheading:16380594-Humans,
pubmed-meshheading:16380594-Phenotype,
pubmed-meshheading:16380594-Triolein
|
pubmed:year |
2005
|
pubmed:articleTitle |
Adrenoleukodystrophy: new approaches to a neurodegenerative disease.
|
pubmed:affiliation |
Author Affliations: Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Md 21205, USA. moser@kennedykrieger.org
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|